Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2009 - 2026)

Zimmer Biomet Holdings' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 238300000.0 for Q1 2026.

• On a quarterly basis, Income from Continuing Operations rose 30.58% year-over-year to 238300000.0 in Q1 2026; TTM through Mar 2026 was 197500000.0, a 251.81% decrease from a year earlier, with the FY2025 full-year figure at 253200000.0, down 310.3% from the prior year.
• Income from Continuing Operations rose to 238300000.0 in Q1 2026 per ZBH's latest filing, from 820400000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 419700000.0 in Q4 2023 and bottomed at 820400000.0 in Q4 2025.
• The 5-year median for Income from Continuing Operations is 182500000.0 (2025), against an average of 94100000.0.
• Across the five-year window, Income from Continuing Operations surged 778.03% in 2023 and plunged 229.78% in 2024, its largest moves.
• Year by year, Income from Continuing Operations stood at 47800000.0 in 2022, then soared by 778.03% to 419700000.0 in 2023, then plunged by 229.78% to 544700000.0 in 2024, then slumped by 50.62% to 820400000.0 in 2025, then surged by 129.05% to 238300000.0 in 2026.
• Per Business Quant, the three latest ZBH Income from Continuing Operations figures stand at 238300000.0 (Q1 2026), 820400000.0 (Q4 2025), and 231200000.0 (Q3 2025).